🇺🇸 FDA
Pipeline program

Tongjiang granule

2021XLA117-3

Phase 2 small_molecule active

Quick answer

Tongjiang granule for Gastroesophageal Reflux is a Phase 2 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Gastroesophageal Reflux
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials